Clinical consequences of antibody formation, serum concentrations, and HLA-Cw6 status in psoriasis patients on Ustekinumab [PDF]
, 2019 Background: Ustekinumab for the treatment of psoriasis is currently administered in a standard dosing regimen. However, some patients tend to benefit from alternative dosing regimens, a step toward personalized medicine.
Busard, Celine, I +9 more
core +1 more source
Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis [PDF]
, 2016 Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the outcome of therapy and of the development of comorbidities.
Cavaliere, Arturo +2 more
core +2 more sources
Secukinumab for plaque psoriasis
Medwave, 2018 Biological treatments have appeared as the main alternative for the management of patients with plaque psoriasis that do not respond to conventional treatment. So, evaluating its actual efficacy and safety is needed.We searched in Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information ...
Gonzalo Ordenes-Cavieres +1 more
openaire +4 more sources
Coronary Plaque Characterization in Psoriasis [PDF]
Circulation, 2017 Article, see p 263 Psoriasis is a chronic immune-mediated disease that affects both the skin and joints in 30% to 35% of patients.1 Clinically, it is characterized by well-demarcated, erythematous plaques covered by silvery-white scales, traditionally affecting the elbows, knees, and scalp.
Dario, Kivelevitch +2 more
openaire +2 more sources
Psoriasis today: experiences of healthcare and impact on quality of life in a major UK cohort [PDF]
, 2015 Aim: To establish how people with psoriasis in the United Kingdom today experience living with their condition including diagnosis, treatment, healthcare provision and impact on daily life.
Gilbert, Annie +4 more
core +1 more source
Stigmatization among Patients with Plaque Psoriasis
Journal of Clinical Medicine, 2023 The aim of the study was to analyze the level of stigmatization among patients with plaque psoriasis according to their demographic and clinical characteristics. The study included 122 patients who completed the 6-item and 33-item Feelings of Stigmatization Questionnaire and a sociodemographic survey.
Barbara Jankowiak +3 more
openaire +3 more sources
Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring
Indian Dermatology Online Journal, 2016 On the basis of current evidence derived from hospital-based studies, mostly from North India, the prevalence of psoriasis in adults varies from 0.44 to 2.8%, with a much lower prevalence in children.
Sunil Dogra, Rahul Mahajan
doaj +1 more source
Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician's Experience. [PDF]
, 2020 Goeckerman therapy is a highly effective treatment regimen for moderate-to-severe psoriasis. It involves regular exposure to ultraviolet B radiation and the application of crude coal tar.
Bhutani, Tina +5 more
core
Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% [PDF]
, 2012 Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders.
Ayres JW +30 more
core +1 more source
Secukinumab versus adalimumab for psoriatic arthritis: comparative effectiveness up to 48 weeks using a matching-adjusted indirect comparison [PDF]
, 2018 Secukinumab and adalimumab are approved for adults with active psoriatic arthritis (PsA). In the absence of direct randomized controlled trial (RCT) data, matching-adjusted indirect comparison can estimate the comparative effectiveness in anti-tumor ...
Gandhi, Kunal +8 more
core +2 more sources